Our clinical development solution is based on industry-leading product portfolios from CLC bio and Ingenuity Systems, both acquired by QIAGEN in 2013. Now fully integrated into a QIAGEN sample-to-insight workflow, these products enable best-in-class clinical test development for labs interested in expanding their personalized medicine test offerings. With this solution, labs can easily and quickly improve variant calling and interpretation pipelines for NGS tests during the analytical test development phase.
© QIAGEN 2017. All rights reserved - Trademarks & Disclaimers